Report Id: SNS/HC/1897 | June 2022 | Region: Global | 125 Pages
Report Scope & Overview:
The Antimicrobial Susceptibility Testing Market Size was valued at USD 3.38 billion in 2021, and is expected to reach USD 5.06 billion by 2028, and grow at a CAGR of 5.9% over the forecast period 2022-2028.
The Antimicrobial Susceptibility Testing is a laboratory test that trained laboratory scientists and medical technologists use to determine if an antimicrobial regimen is effective for each patient. The primary goal of the Antimicrobial Susceptibility Test is to determine whether or not antibiotic medicine will work. To guarantee that the results can be repeated, these tests are conducted under controlled conditions. The results of this test help determine which antibiotic is best for the patient.
Antimicrobial Susceptibility Testing is performed on a regular basis to ensure that antibiotics are effectively used. It determines the lowest amounts of novel or existing antimicrobial medicines that inhibit the bacterium under research from growing in a consistent and detectable manner in specific test circumstances. It entails finding drug resistance in some of the most common ailments as well as determining the susceptibility of preferred treatments to certain infections.
Antimicrobial resistance occurs as a result of a misdiagnosis of an infectious disease, a lack of adequate treatment guidelines, and non-adherence to the treatment plan. Superbug infection thrives in primary healthcare facilities in both developed and developing nations. Antibiotic resistance is a hot topic among microbiologists, who are trying to figure out what causes it and how to avoid it. In addition, broad-spectrum antibiotics for the treatment of microbial infections are being developed.
Advancements in technology
Government efforts to detect and control antimicrobial-resistant species are becoming more widespread.
Drug misuse leads to the development of multidrug resistance.
Infectious diseases are rampant, and epidemics and epidemics are increasingly common.
Increased market support, research grants, and public-private partnerships
Automated ID/AST systems are extremely expensive.
Markets that are still developing
Initiatives to raise awareness about antimicrobial resistance and its management
Antimicrobial testing approvals are slowed by complex regulatory procedures.
IMPACT OF COVID-19
As a result of this epidemic, access to customers to market and deploy automated AST systems (such as the Accelerate Pheno system, MicroScan WalkAway, and Sensitarian ARIS system) declined in March and the second quarter of 2020, as hospitals focused exclusively on COVID. -19 disease. Due to limited access to current and potential customers, market players have not been able to complete the sale of new AST systems and use previously sold systems, resulting in a slowdown in the growth of affordable testing services. Moreover, the market expects to recoup its losses in the fourth quarter of 2020.
By Product Type
Automated laboratory tools, antimicrobial Susceptibility testing equipment, culture and growth media, and materials make up the anti-bacterial testing industry. Slope test discs, MIC strips, and slope test plates are examples of antimicrobial test products. The AST market was full of products to test trends. The segment is projected to increase due to improved germ resistance, roll-out of new products, and increased acceptance of risk-testing discs in developing countries.
Antibacterial, antifungal, antiparasitic, and other susceptibility testing are the different types of antimicrobial susceptibility testing available. The antimicrobial susceptibility testing segment dominated the market. Overuse of broad-spectrum antibiotics, as well as the advent of multidrug resistance, are responsible for the majority of this category. Medication resistance develops in bacteria as a result of the misuse of broad-spectrum antibiotics, necessitating better drug screening. The timely selection of the appropriate treatment therapy is aided by early availability of information on bacterial infections and their antibiotic susceptibility, which plays a key role in illness management.
By Method Type
Disk diffusion, agar dilution, ETEST, automated antimicrobial susceptibility testing tools, and genotypic approaches are the market segments for antimicrobial susceptibility testing. The automated antimicrobial susceptibility testing devices segment had the greatest proportion of the market among these approaches. Speed, precision, and the ability to provide qualitative and quantitative susceptibility results account for the majority of the segment's revenue. Furthermore, technical developments and increased R&D spending by key firms are fueling the segment's expansion.
By End User
Diagnostic Centers and Hospitals, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), and Research and Education Institutions are four market segments. Antifungal testing procedures performed in diagnostic laboratories and hospitals, as well as an increase in the number of hospitals in major markets. The development of health care infrastructure is expected to have an impact on the field of antibiotic sensitivity testing. The installation and use of highly sophisticated, efficient, and advanced equipment to test the effectiveness of antiretroviral drugs and procedures in health facilities around the world has made it possible for government investment in health care.
Some of the major key players are as follows: Bio-Rad, BD, Danaher, Thermo Fisher Scientific, Accelerate Diagnostics, Merck Group, Creative Diagnostics, Alifax, Roche Diagnostics Limited, and Synbiosis.
Manual Antimicrobial Susceptibility Testing Products
Automated Laboratory Instruments
Culture and Growth Media
Antibacterial Susceptibility Testing
Antifungal Susceptibility Testing
Antiparasitic Susceptibility Testing
Other Susceptibility Testing Types (slow-growing pathogens)
Automated Susceptibility Testing Instruments
By End User
Hospitals and Diagnostic Centers
Pharmaceutical and Biotechnology Companies
Research &Academic Institutes
Clinical Research Organizations (CROs)
North America now holds the bulk of the worldwide antimicrobial susceptibility testing market share, and is expected to do so for the foreseeable future. This is due to a growth in antibiotic resistance, the presence of significant players, increased healthcare spending, technological improvements, and increased government actions in the region. However, due to an increase in the general population and greater investments in the region's healthcare industry, Asia-Pacific is expected to experience significant development.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
|Market Size in 2021||US$ 3.38 Billion|
|Market Size by 2028||US$ 5.06 Billion|
|CAGR||CAGR of 5.9% From 2022 to 2028|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Product (Manual Antimicrobial Susceptibility Testing Products, Automated Laboratory Instruments, Culture and Growth Media, Consumables)
• By Type (Antibacterial Susceptibility Testing, Antifungal Susceptibility Testing, Antiparasitic Susceptibility Testing, Other Susceptibility Testing Types (slow-growing pathogens))
• By Method (Etest Method, Disk Diffusion, Automated Susceptibility Testing Instruments, Agar Dilution, Genotyping Methods)
• By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research &Academic Institutes, Clinical Research Organizations (CROs))
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Bio-Rad, BD, Danaher, Thermo Fisher Scientific, Accelerate Diagnostics, Merck Group, Creative Diagnostics, Alifax, Roche Diagnostics Limited, and Synbiosis.|
|DRIVERS||• Advancements in technology
• Government efforts to detect and control antimicrobial-resistant species are becoming more widespread.
• Drug misuse leads to the development of multidrug resistance.
|RESTRAINTS||• Automated ID/AST systems are extremely expensive.|
Frequently Asked Questions (FAQ) :
Antimicrobial Susceptibility Testing market is expected grow at a CAGR of 5.9% over the forecast period 2022-2028.
Automated ID/AST systems are extremely expensive are the restraints of Antimicrobial Susceptibility Testing Market
Antimicrobial Susceptibility Testing Market is divided into four segments and they are By Product, By Type, By Method, and By End User.
North America now holds the bulk of the worldwide antimicrobial susceptibility testing market share, and is expected to do so for the foreseeable future.
The antimicrobial susceptibility testing segment dominated the market.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID 19 Impact Analysis
4.2 Impact of Ukraine ware
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Antimicrobial Susceptibility Testing Market Segmentation, By Product
8.1 Manual Antimicrobial Susceptibility Testing Products
8.2 Automated Laboratory Instruments
8.3 Culture and Growth Media
9. Antimicrobial Susceptibility Testing Market Segmentation, By Type
9.1 Antibacterial Susceptibility Testing
9.2 Antifungal Susceptibility Testing
9.3 Antiparasitic Susceptibility Testing
9.4 Other Susceptibility Testing Types (slow-growing pathogens)
10. Antimicrobial Susceptibility Testing Market Segmentation, By Method
10.1 Etest Method
10.2 Disk Diffusion
10.3 Automated Susceptibility Testing Instruments
10.4 Agar Dilution
10.5 Genotyping Methods
11. Antimicrobial Susceptibility Testing Market Segmentation, By End User
11.1 Hospitals and Diagnostic Centers
11.2 Pharmaceutical and Biotechnology Companies
11.3 Research &Academic Institutes
11.4 Clinical Research Organizations (CROs)
12. Regional Analysis
12.2 North America
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4.2 South Korea
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.3 South Africa
12.6 Latin America
12.6.3 Rest of Latin America
13 Company Profiles
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.4 Thermo Fisher Scientific
13.5 Accelerate Diagnostics
13.6 Merck Group
13.7 Creative Diagnostics
13.9 Roche Diagnostics Limited
14 Competitive Landscape
14.1 Competitive Benchmark
14.2 Market Share analysis
14.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.